Immune Pharmaceuticals to Present at the JMP Securities...

2016-06-21T11:57:37-07:00

NEW YORK, June 20, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company announced today that Dr. Daniel Teper, Chief Executive Officer, will be presenting at ...